Brookstone Capital Management’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-6,785
Closed -$220K 769
2022
Q1
$220K Buy
6,785
+292
+4% +$9.13K ﹤0.01% 713
2021
Q4
$234K Buy
+6,493
New +$202K ﹤0.01% 682
2021
Q3
Sell
-6,197
Closed -$210K 736
2021
Q2
$210K Sell
6,197
-1,985
-24% -$65.7K ﹤0.01% 673
2021
Q1
$228K Buy
+8,182
New +$218K 0.01% 445
2019
Q4
Sell
-78,113
Closed -$1.17M 426
2019
Q3
$1.17M Sell
78,113
-30,950
-28% -$503K 0.06% 168
2019
Q2
$2.62M Buy
+109,063
New +$3.21M 0.15% 110
2015
Q4
Sell
-589
Closed -$4K 257
2015
Q3
$4K Buy
+589
New +$6.17K ﹤0.01% 1514

Other funds holding CC

Brookstone Capital Management's CC Position: Q2 2022 in Review

Brookstone Capital Management sold out of Chemours (CC) in Q2 2022, closing a stake of 6,785 shares — an estimated $220K sold.

Brookstone Capital Management first reported a position in CC in Q3 2015 and held it in 7 quarters. The position peaked at $2.62M in Q2 2019. 517 funds tracked by Wall St. Rank hold CC as of Q2 2022.

  • Brookstone Capital Management reported no remaining Chemours position as of Q2 2022 after selling out during the quarter.
  • Brookstone Capital Management sold 6,785 Chemours shares in Q2 2022, an estimated $220K.
  • Brookstone Capital Management first reported a position in Chemours in Q3 2015 and held it in 7 quarters.
  • Brookstone Capital Management's Chemours position peaked at $2.62M in Q2 2019.
  • 517 funds tracked by Wall St. Rank held Chemours as of Q2 2022.

Based on Brookstone Capital Management's 13F filing for Q2 2022, filed 11 Jul 2022.